219 results
Page 2 of 11
8-K
97a6t7
2 Oct 23
Entry into a Material Definitive Agreement
5:15pm
424B5
i9sbpfiep 8az4
2 Oct 23
Prospectus supplement for primary offering
5:10pm
424B5
9vu7tauoj9rgv
28 Sep 23
Prospectus supplement for primary offering
4:01pm
8-K
EX-10.1
g6av6e0h2v
13 Sep 23
Departure of Directors or Certain Officers
4:30pm
8-K
EX-99.1
5d2xj q2r72um
13 Sep 23
Madrigal Pharmaceuticals Announces NDA Acceptance and Priority Review of the New Drug
4:25pm
S-8
EX-99.2
ypdxo910 7qcw2w6
11 Sep 23
Registration of securities for employees
4:31pm
S-8
EX-99.3
rfj47e755rtnf937i1xi
11 Sep 23
Registration of securities for employees
4:31pm
424B3
vt5sth 5cuthoify3e6a
8 Aug 23
Prospectus supplement
9:19am
8-K
EX-99.1
91rxfasgm8yhd
8 Aug 23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports Second Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
ryrnegh
17 Jul 23
Other Events
8:00am
8-K
EX-99.1
7sc2zxdxm e0
30 Jun 23
Madrigal expects to complete full submission of the New Drug Application in July 2023
8:00am
424B5
o9fc 958u
9 May 23
Prospectus supplement for primary offering
9:02am
8-K
EX-99.1
jcbs99u5rvx qq19mu2l
9 May 23
Madrigal Pharmaceuticals Provides Corporate Updates and Reports First Quarter 2023 Financial Results
8:00am